2024-12-2920241068-926510.1245/s10434-024-15728-52-s2.0-85198381866https://doi.org/10.1245/s10434-024-15728-5https://hdl.handle.net/20.500.14288/22034OncologySurgeryASO author reflections: prognostic value of subgrading G2 pancreatic neuroendocrine tumors as 2A versus 2BOther1534-46811271254500002Q240149